All News

A new initiative has been launched at the University of North Carolina to create and share tools to fight rare diseases.

The payment reforms introduced in the Medicare Access and CHIP Reauthorization Act make the medical home care model more relevant than ever.

President-elect Donald J. Trump held a news conference in New York Wednesday on a wide range of topics, but a recurring theme was the future of healthcare. Here are 5 things we learned about Trump’s plans for healthcare at Wednesday’s conference.

The study found that, if anything, children with private coverage are being admitted to the hospital too often, raising questions about the allocation of healthcare resources.

This week, the top stories in managed care were that the Senate began the process of repealing the Affordable Care Act, Cigna and CVS moved away from the EpiPen, and the NCI Formulary will make it easier to study cancer drugs and their combinations.

The American Society of Clinical Oncology (ASCO) hopes that the principles will help ensure access to healthcare and adequate insurance, to improve outcomes among those diagnosed with cancer.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

The new definition applies to CGM devices that have FDA approval for dosing decisions. Right now, Dexcom's G5 meets the 5-part test.

What we're reading, January 13, 2017: more states consider contraception laws with Affordable Care Act (ACA) in peril; GOP will speed up timeline to replace ACA; Tom Price will sell his stocks to avoid conflicts.

Research published in the Journal of Oncology Practice has identified high treatment burden among Medicare patients with early-stage non—small cell lung cancer (NSCLC).

The continued segmentation of the US healthcare system has resulted in a majority of spending on behavioral health disorders being attributed to treatment of the physical comorbidities.

Shortly after Cigna announced it would stop covering the name-brand EpiPen, CVS declared it would begin selling a cheaper generic version of the costly epinephrine injector. Earlier in the week, Heather Bresch, CEO of EpiPen manufacturer Mylan, had reflected on the controversy surrounding the device’s price.

The World Health Organization has called for limiting soda marketing to kids, and the authors describe the holiday truck as a item that needs to go.

What we're reading, January 12, 2017: Republicans begin process of repealing Obamacare by passing budget resolution; AbbVie's CEO promises to keep drug price increases to once a year and less than 10%; Cardinal Health will pay $44 million for not reporting suspicious opioid orders.

A conglomerate of 69 National Cancer Institute—designated cancer centers has come together to endorse the CDC’s recommendations for HPV vaccination of young children.

As healthcare continues to see high-profile data breaches, underwriters are looking for third-party accreditation before issuing cyber-security policies.

If the Affordable Care Act is repealed, providers of the Diabetes Prevention Program will need to replace the path to Medicare reimbursement that were covered in the law.

Described as a public—private partnership between the National Cancer Institute (NCI) and pharmaceutical and biotechnology companies, the NCI Formulary is expected to provide researchers rapid access to anticancer drugs for use in clinical trials.

Researchers have found that accountable care organizations with a higher proportion of minority patients tend to score worse on Medicare’s quality performance measures.

The governor's plan takes aim at prior authorization from insurers and seeks a prescription cap of a 5-day supply, which would be stricter than the revamped CDC guidelines.

President-elect Donald J. Trump's transition team declined to confirm that vaccine skeptic Robert F. Kennedy, Jr., would head a vaccine safety commission in the new administration, but the move would be consistent with Trump's prior positions on vaccination and autism.

What we're reading, January 11, 2017: in the last 2 decades, the drug pipeline hasn't gotten any faster; smoking and its side effects cost world economies $1 trillion; and Maryland introduces 2 bills aimed at curbing drug prices.

A screening study conducted over 2 decades in Denmark has raised questions about the need and implications of biennial mammography for women between 50 and 69 years of age.

Director Tom Frieden, MD, MPH, said the results show that a population health—based approach can save lives and money when there are "rigorous" standards for accountability.

Researchers from the Memorial Sloan Kettering Cancer Center have developed a novel method using modified donor T cells to make stem cell transplants both safer and more effective for treating blood cancers

A recent study in Health Affairs indicated that insurers with greater market shares are better able to negotiate lower prices, particularly from larger provider groups. The findings could have far-reaching implications as insurers continue to merge and smaller provider groups face lower payments.

The ruling means that barring a settlement or a reversal on appeal, Sanofi and Regeneron could be forced to stop selling Praluent within 6 weeks.

What we're reading: the Obama administration promises swift action on North Carolina's Medicaid expansion plan; FDA approves long-acting opioid; and a look at where President Barack Obama and President-elect Donald J. Trump stand on 5 areas of health policy and science.

The study observed significant shifts in the treatment of advanced-stage non-small cell lung cancer (NSCLC), accompanied by only modest gains in survival and total Medicare spending.

Rising healthcare expenditures, leading to increased consumer cost sharing, is a top concern in healthcare that crosses party lines. In a new commentary in JAMA Internal Medicine, A. Mark Fendrick, MD, and Michael E. Chernew, PhD, co-editors-in-chief of The American Journal of Managed Care, highlighted the need for a “smarter” deductible.